Reviva Pharmaceuticals
RVPH
RVPH
48 hedge funds and large institutions have $6.94M invested in Reviva Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
45% less call options, than puts
Call options by funds: $2.25M | Put options by funds: $4.13M
50% less capital invested
Capital invested by funds: $14M → $6.94M (-$7.07M)
Holders
48
Holding in Top 10
–
Calls
$2.25M
Puts
$4.13M
Top Buyers
| 1 | +$621K | |
| 2 | +$400K | |
| 3 | +$325K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$213K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$206K |
Top Sellers
| 1 | -$2.47M | |
| 2 | -$931K | |
| 3 | -$763K | |
| 4 |
Millennium Management
New York
|
-$258K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$84.1K |
